In Vitro Modeling of the Antitumor Drugs Effects on the Endothelial Barrier Function

Area of Science:

• Oncology
• Vascular Biology
• Drug Development

Background:

• Anticancer therapies can cause pulmonary edema and acute respiratory failure due to vascular endothelium dysfunction.
• Current drug development lacks models to predict endothelial cell toxicity early.
• Identifying safe anticancer drug doses is crucial for patient outcomes.

Purpose of the Study:

• To establish an in vitro model for evaluating vascular response during anticancer drug development.
• To determine if effective antitumor drug doses can be selected without harming endothelial cell function.
• To investigate the pathological effects of anticancer drugs on endothelial cells.

Main Methods:

• Experimentally determined doses of clinically used antitumor drugs that suppress tumor cell proliferation.
• Assessed endothelial cell viability in vitro after exposure to selected drug doses.
• Utilized intravital observations and super-resolution microscopy to study endothelial cell changes and intracellular disorders.

Main Results:

• Identified specific antitumor drug concentrations that inhibit tumor cell proliferation.
• Demonstrated that these selected concentrations do not critically affect endothelial cell viability or cytoskeletal structures.
• Successfully created an in vitro model system for assessing drug-induced vascular permeability changes.

Conclusions:

• The developed in vitro model enables the selection of anticancer drugs with improved safety profiles.
• This model aids in optimizing drug development by predicting and mitigating vascular side effects.
• It facilitates the identification of therapeutic windows for anticancer agents, balancing efficacy and endothelial safety.